PT  - JOURNAL ARTICLE
AU  - Burke, Eva
AU  - Watson, Katherine
AU  - Eva, Gillian
AU  - Gold, Judy
AU  - Garcia-Moreno, Claudia
AU  - Amin, Avni
TI  - Is addressing violence against women prioritised in health policies? Findings from a WHO Policies Database
AID  - 10.1101/2023.09.28.23296312
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.09.28.23296312
4099  - http://medrxiv.org/content/early/2023/09/29/2023.09.28.23296312.short
4100  - http://medrxiv.org/content/early/2023/09/29/2023.09.28.23296312.full
AB  - Violence against women (VAW) affects almost 1 in 3 women and can lead to short and long-term adverse health outcomes. The health sector is an important entry point to respond to VAW. Globally, countries have committed to eliminating VAW through the SDGs and WHO Member States have endorsed a Global Plan of Action on Violence, which asks countries to provide comprehensive health services to VAW survivors. To track progress and establish a baseline for the Global Plan of Action on Violence, WHO developed a VAW Policies Database to assess how countries are addressing VAW in health and multisectoral policies. This paper presents findings from 15 select indicators related to the existence of VAW-related policies and the inclusion of health services for survivors in policies in line with WHO recommendations. Results show that while 80% of countries have multisectoral VAW policies in place, only 34% have national health policies that include VAW response and/or prevention as a strategic priority, and 48% have clinical guidelines for the health sector response. Policies were analysed to identify inclusion of WHO-recommended VAW health services: 75% of countries’ policies mention provision of first-line support; while 50% or fewer of countries mention clinical enquiry to identify intimate partner violence, post-rape care services, or mental health assessment, referral and treatment. The high-income countries group had the lowest proportion of countries that specified each of the above-mentioned health services in policies. Findings show that more efforts are needed to raise the awareness of ministries of health about the public health impact of VAW and the importance of including VAW in health policies. Where policies exist, many are not aligned with WHO-recommendations. Policy dialogues should be conducted with governments on how to better align their VAW policies with internationally-agreed, evidence-based standards, and to implement them through programmes and services.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis manuscript was prepared with the financial support of the World Health Organization’s Department of Sexual and Reproductive Health and Research that includes the UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research on Human Reproduction (HRP). Funding for the research was also provided by the Foreign, Commonwealth and Development Office (FCDO) of the Government of the United Kingdom and Great Britain. Initials of author who received the reward: AA. URL for website: https://www.who.int/teams/sexual-and-reproductive-health-and-research-(srh) No commercial companies funded the study or authors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was not required as the research was based on secondary analysis of policies, and thus no individual data was collected or included.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData reflect WHO Member State information and are not yet publicly available. They can be requested from the WHO secretariat and access will be considered on a case by case basis.